94 related articles for article (PubMed ID: 36002997)
1. Where does SARS-CoV-2 go to in man?
Lucas S
J Pathol; 2022 Nov; 258(3):211-212. PubMed ID: 36002997
[TBL] [Abstract][Full Text] [Related]
2. Multisystem screening reveals SARS-CoV-2 in neurons of the myenteric plexus and in megakaryocytes.
Gray-Rodriguez S; Jensen MP; Otero-Jimenez M; Hanley B; Swann OC; Ward PA; Salguero FJ; Querido N; Farkas I; Velentza-Almpani E; Weir J; Barclay WS; Carroll MW; Jaunmuktane Z; Brandner S; Pohl U; Allinson K; Thom M; Troakes C; Al-Sarraj S; Sastre M; Gveric D; Gentleman S; Roufosse C; Osborn M; Alegre-Abarrategui J
J Pathol; 2022 Jun; 257(2):198-217. PubMed ID: 35107828
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Spike Protein Destabilizes Microvascular Homeostasis.
Panigrahi S; Goswami T; Ferrari B; Antonelli CJ; Bazdar DA; Gilmore H; Freeman ML; Lederman MM; Sieg SF
Microbiol Spectr; 2021 Dec; 9(3):e0073521. PubMed ID: 34935423
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45
Ratajczak MZ; Bujko K; Ciechanowicz A; Sielatycka K; Cymer M; Marlicz W; Kucia M
Stem Cell Rev Rep; 2021 Feb; 17(1):266-277. PubMed ID: 32691370
[TBL] [Abstract][Full Text] [Related]
5. The SARS-CoV-2 receptor ACE2 is expressed in mouse pericytes but not endothelial cells: Implications for COVID-19 vascular research.
Muhl L; He L; Sun Y; Andaloussi Mäe M; Pietilä R; Liu J; Genové G; Zhang L; Xie Y; Leptidis S; Mocci G; Stritt S; Osman A; Anisimov A; Hemanthakumar KA; Räsänen M; Hansson EM; Björkegren J; Vanlandewijck M; Blomgren K; Mäkinen T; Peng XR; Hu Y; Ernfors P; Arnold TD; Alitalo K; Lendahl U; Betsholtz C
Stem Cell Reports; 2022 May; 17(5):1089-1104. PubMed ID: 35452595
[TBL] [Abstract][Full Text] [Related]
6. Understanding on the possible routes for SARS CoV-2 invasion via ACE2 in the host linked with multiple organs damage.
Kirtipal N; Kumar S; Dubey SK; Dwivedi VD; Gireesh Babu K; Malý P; Bharadwaj S
Infect Genet Evol; 2022 Apr; 99():105254. PubMed ID: 35217145
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1.
Shin J; Toyoda S; Nishitani S; Onodera T; Fukuda S; Kita S; Fukuhara A; Shimomura I
Metabolism; 2022 Aug; 133():155236. PubMed ID: 35688210
[TBL] [Abstract][Full Text] [Related]
8. Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses.
Nascimento Conde J; Schutt WR; Gorbunova EE; Mackow ER
mBio; 2020 Dec; 11(6):. PubMed ID: 33310781
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the SARS-CoV-2 receptor ACE2 is induced by cigarette smoke in bronchial and alveolar epithelia.
Liu A; Zhang X; Li R; Zheng M; Yang S; Dai L; Wu A; Hu C; Huang Y; Xie M; Chen Q
J Pathol; 2021 Jan; 253(1):17-30. PubMed ID: 32991738
[TBL] [Abstract][Full Text] [Related]
10. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.
Ni W; Yang X; Yang D; Bao J; Li R; Xiao Y; Hou C; Wang H; Liu J; Yang D; Xu Y; Cao Z; Gao Z
Crit Care; 2020 Jul; 24(1):422. PubMed ID: 32660650
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
Kuba K; Yamaguchi T; Penninger JM
Front Immunol; 2021; 12():732690. PubMed ID: 35003058
[TBL] [Abstract][Full Text] [Related]
12. Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2.
Zhao X; Chen D; Szabla R; Zheng M; Li G; Du P; Zheng S; Li X; Song C; Li R; Guo JT; Junop M; Zeng H; Lin H
J Virol; 2020 Aug; 94(18):. PubMed ID: 32661139
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 interacts with platelets and megakaryocytes via ACE2-independent mechanism.
Shen S; Zhang J; Fang Y; Lu S; Wu J; Zheng X; Deng F
J Hematol Oncol; 2021 Apr; 14(1):72. PubMed ID: 33926500
[TBL] [Abstract][Full Text] [Related]
14. Effects of cigarette smoking on SARS-CoV-2 receptor ACE2 expression in the respiratory epithelium
Heijink IH; Hackett TL; Pouwels SD
J Pathol; 2021 Apr; 253(4):351-354. PubMed ID: 33368245
[TBL] [Abstract][Full Text] [Related]
15. Epithelial and Endothelial Expressions of ACE2: SARS-CoV-2 Entry Routes.
Guney C; Akar F
J Pharm Pharm Sci; 2021; 24():84-93. PubMed ID: 33626315
[TBL] [Abstract][Full Text] [Related]
16. Evidence of SARS-CoV2 Entry Protein ACE2 in the Human Nose and Olfactory Bulb.
Klingenstein M; Klingenstein S; Neckel PH; Mack AF; Wagner AP; Kleger A; Liebau S; Milazzo A
Cells Tissues Organs; 2020; 209(4-6):155-164. PubMed ID: 33486479
[TBL] [Abstract][Full Text] [Related]
17. Putative mechanism of neurological damage in COVID-19 infection.
Bandala C; Cortes-Altamirano JL; Reyes-Long S; Lara-Padilla E; Ilizaliturri-Flores I; Alfaro-Rodríguez A
Acta Neurobiol Exp (Wars); 2021; 81(1):69-79. PubMed ID: 33949163
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells.
Suzuki YJ; Nikolaienko SI; Dibrova VA; Dibrova YV; Vasylyk VM; Novikov MY; Shults NV; Gychka SG
Vascul Pharmacol; 2021 Apr; 137():106823. PubMed ID: 33232769
[TBL] [Abstract][Full Text] [Related]
19. Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2.
Liu Y; Hu G; Wang Y; Ren W; Zhao X; Ji F; Zhu Y; Feng F; Gong M; Ju X; Zhu Y; Cai X; Lan J; Guo J; Xie M; Dong L; Zhu Z; Na J; Wu J; Lan X; Xie Y; Wang X; Yuan Z; Zhang R; Ding Q
Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33658332
[TBL] [Abstract][Full Text] [Related]
20. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
